Home
Articles
Classified Ads
Links
Books
Contact Us

 

 

 

 

 


ALBATROSS
PUBLICATIONS

PO Box 523
Horsham
West Sussex
RH12 4WL

Tel:
01293 871201

Fax:
01293 871301

VACCINE UPDATE - 2002
Part 2

Trevor Turner, B. Vet. Med., MRCVS


CONTENTS:


WHAT'S NEW IN VACCINES?

Meriel are currently advertising their new Euricel range as "pure flexibility." These vaccines are an innovative range. Euricel FeLV is advertised as the UK's only non-adjuvanted feline leukaemia vaccine, in other words this is not a 'killed' vaccine. In order to increase the potency of most killed vaccines they are adjuvanted, in other words combined with another substance which increases the antigenic mass or potency of the vaccine. It is these adjuvants which are thought to be responsible for some of the untoward reactions that can occur, particularly in the case of cat vaccines and vaccine induced sarcomas.

Up to now, due to the risk of shedding, live attenuated FeLV vaccines have not been used in this country. Leucogen, produced by Virbac, is an example. Genetic engineering is employed. The original FeLV antigen responsible for the production of antibodies is incorporated into a strain of bacteria. The antigenic material is then adjuvanted. This increases the efficacy of the vaccine.

Leucocel 2 produced by Pfizer is a plain, straightforward inactivated adjuvanted sub-unit feline leukaemia virus vaccine.

Euricel FeLV is totally novel. Here the FeLV antigen is incorporated into a canary pox virus which has the property of being able to infect the cat's cells but cannot reproduce within mammalian cells. Therefore there is no chance of replication and shedding or the chance of spreading FeLV.

Carrying the correct antigens to stimulate immunity to FeLV, this is indeed a break through since no adjuvants are used and consequently the risk of adverse reactions is reduced.

A similar type of technology has been used in the recombinant oral rabies vaccine which is being used very successfully to eradicate rabies from the Red Fox population in central Europe.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RABIES VACCINES

In this connection it is interesting to note that the two rabies vaccines shown in the list, Rabisin from Merial and Nobivac Rabies from Intervet are both inactivated killed vaccines. This is because in the past, in North America, when attenuated vaccines were investigated there was the possibility of shedding the virus and therefore the safer, killed vaccine is used.

I wonder how long we will have to wait before recombitant rabies vaccines are available in this country for dogs and cats?

I mentioned earlier that inactivated killed vaccines generally produce a shorter effective immunce response. Some countries insist on annual rabies vaccination. However with Nobivac Rabies inactivated vaccine Intervet recommend dogs and cats are re-vaccinated every two years. The adjuvant used is aluminium phosphate. Merial also produce a similar inactivated Rabies vaccine (Rabisin) but use a different technique, growing the virus on cells originating from hamster embryo cell culture. Aluminium hydroxideis is used as an adjuvant and a two year booster interval in dogs is recommended by the manufacturer and one year for cats. It would therefore seem sensible to use Nobivac Rabies vaccine since it gives two years immunity for dogs and cats. The difficulty then is that certain countries operating under the PETS scheme require annual rabies booster vaccination for both dogs and cats.

I faced this dilemma recently when presented with a cat with a request for a rabies booster only to find that its Nobivac rabies had still a year to run.

Clearly if the owners were going to return to their country of origin with the cat, a booster had to be put in but if as a result of this there is any untoward reaction, would I be accused of using the product without the manufacturer's recommendation?

Vaccines and vaccine policies are changing. This has to be for the ultimate good the patient but in the meantime I think it might cause us, as kennel owners and managers, a few headaches on the way.